Cancer Prevention by Natural Products Introduced into the Diet-Selected Cyclitols.

Abstract

Cancer is now the second leading cause of death worldwide. It is estimated that every year, approximately 9.6 million people die of oncologic diseases. The most common origins of malignancy are the lungs, breasts, and colorectum. Even though in recent years, many new drugs and therapeutic options have been introduced, there are still no safe, effective chemopreventive agents. Cyclitols seem poised to improve this situation. There is a body of evidence that suggests that their supplementation can decrease the incidence of colorectal cancer, lower the risk of metastasis occurrence, lower the proliferation index, induce apoptosis in malignant cells, enhance natural killer (NK) cell activity, protect cells from free radical damage, and induce positive molecular changes, as well as reduce the side effects of anticancer treatments such as chemotherapy or surgery. Cyclitol supplementation appears to be both safe and well-tolerated. This review focuses on presenting, in a comprehensive way, the currently available knowledge regarding the use of cyclitols in the treatment of different malignancies, particularly in lung, breast, colorectal, and prostate cancers.

• Authors: Karol Wiśniewski, Marcin Jozwik, Joanna Wojtkiewicz
• Journal: International journal of molecular sciences (Int J Mol Sci) Vol. 21 Issue 23 (Nov 26 2020) ISSN: 1422-0067 [Electronic] Switzerland
• PMID: 33256104 (Publication Type: Journal Article, Review)

Chemical References

• Antineoplastic Agents
• Biological Products
• Cyclitols

Topics

• Animals
• Antineoplastic Agents (pharmacology, therapeutic use)
• Biological Products (chemistry, pharmacology, therapeutic use)
• Cyclitols (chemistry, pharmacology, therapeutic use)
• Diet
• Humans
• Neoplasms (drug therapy, prevention & control)